Zhu W, Murtha P E, Young C Y
Department of Urology, Mayo Clinic/Foundation, Rochester, MN 55905, USA.
Biochem Biophys Res Commun. 1995 Sep 25;214(3):1130-7. doi: 10.1006/bbrc.1995.2403.
Although it has been shown that calpains may play a positive role in causing apoptosis of T cells, we report here that, on the contrary, the inhibition of calpain-like activities can induce apoptosis in human prostate cancer cells. Two calpain inhibitors were used to test growth response on prostate cancer cells and showed remarkable cytotoxicity. The cytotoxicity was due to apoptosis as judged by large genomic DNA fragmentation, chromatin condensation and nuclear fragmentation. Furthermore, using gel band shift assays we have demonstrated that calpain inhibitor 1 causes a prolonged elevation of AP-1 protein activity in human prostate cancer cells. The elevation of AP-1 activity appears to be specific, because calpain inhibitor 1 only stimulates AP-1 but not AP-2 and SP-1 activities. We postulate that the sustained increase in AP-1 activity may be involved in apoptosis induced in prostate cells by calpain inhibitors. Our study thus suggests that calpain-like activity may be a potentially therapeutic target for cancer.
尽管已有研究表明钙蛋白酶可能在引发T细胞凋亡中发挥积极作用,但我们在此报告,相反地,抑制类钙蛋白酶活性可诱导人前列腺癌细胞凋亡。使用两种钙蛋白酶抑制剂测试其对前列腺癌细胞的生长反应,结果显示出显著的细胞毒性。从大量基因组DNA片段化、染色质凝聚和核碎裂判断,这种细胞毒性是由凋亡引起的。此外,通过凝胶带迁移分析,我们证明钙蛋白酶抑制剂1可导致人前列腺癌细胞中AP - 1蛋白活性长时间升高。AP - 1活性的升高似乎具有特异性,因为钙蛋白酶抑制剂1仅刺激AP - 1,而不刺激AP - 2和SP - 1活性。我们推测,AP - 1活性的持续增加可能与钙蛋白酶抑制剂诱导的前列腺细胞凋亡有关。因此,我们的研究表明,类钙蛋白酶活性可能是癌症潜在的治疗靶点。